Edwards Lifesciences SG&A Expenses 2010-2024 | EW

Edwards Lifesciences annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Edwards Lifesciences sg&a expenses for the quarter ending September 30, 2024 were $0.421B, a 10.34% increase year-over-year.
  • Edwards Lifesciences sg&a expenses for the twelve months ending September 30, 2024 were $1.958B, a 19.41% increase year-over-year.
  • Edwards Lifesciences annual sg&a expenses for 2023 were $1.825B, a 16.39% increase from 2022.
  • Edwards Lifesciences annual sg&a expenses for 2022 were $1.568B, a 4.95% increase from 2021.
  • Edwards Lifesciences annual sg&a expenses for 2021 were $1.494B, a 21.6% increase from 2020.
Edwards Lifesciences Annual SG&A Expenses
(Millions of US $)
2023 $1,825
2022 $1,568
2021 $1,494
2020 $1,228
2019 $1,242
2018 $1,089
2017 $991
2016 $905
2015 $851
2014 $858
2013 $733
2012 $697
2011 $642
2010 $550
2009 $509
Edwards Lifesciences Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $421
2024-06-30 $451
2024-03-31 $490
2023-12-31 $596
2023-09-30 $382
2023-06-30 $410
2023-03-31 $436
2022-12-31 $411
2022-09-30 $377
2022-06-30 $409
2022-03-31 $370
2021-12-31 $424
2021-09-30 $364
2021-06-30 $375
2021-03-31 $331
2020-12-31 $339
2020-09-30 $307
2020-06-30 $275
2020-03-31 $308
2019-12-31 $347
2019-09-30 $306
2019-06-30 $309
2019-03-31 $280
2018-12-31 $288
2018-09-30 $270
2018-06-30 $275
2018-03-31 $256
2017-12-31 $273
2017-09-30 $245
2017-06-30 $244
2017-03-31 $230
2016-12-31 $234
2016-09-30 $230
2016-06-30 $229
2016-03-31 $213
2015-12-31 $222
2015-09-30 $212
2015-06-30 $214
2015-03-31 $203
2014-12-31 $223
2014-09-30 $222
2014-06-30 $216
2014-03-31 $197
2013-12-31 $187
2013-09-30 $178
2013-06-30 $187
2013-03-31 $182
2012-12-31 $170
2012-09-30 $168
2012-06-30 $182
2012-03-31 $177
2011-12-31 $163
2011-09-30 $166
2011-06-30 $163
2011-03-31 $150
2010-12-31 $142
2010-09-30 $133
2010-06-30 $141
2010-03-31 $134
2009-12-31 $132
2009-09-30 $126
2009-06-30 $129
2009-03-31 $122
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.569B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Alcon (ALC) Switzerland $42.414B 28.38
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
DexCom (DXCM) United States $28.447B 42.84
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.35
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 0.00
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.023B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.463B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00